Celensia Tolson1, Lauren E Richey2, Yujing Zhao2, Jeffrey E Korte3, Kathleen Brady4, Louise Haynes5, Eric G Meissner6. 1. Drug Abuse Research Training Program, Medical University of South Carolina, Charleston, South Carolina. 2. Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina. 3. Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina. 4. Drug Abuse Research Training Program, Medical University of South Carolina, Charleston, South Carolina; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina. 5. Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina. 6. Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: meissner@musc.edu.
Abstract
BACKGROUND: Persons with HIV infection who do not achieve virologic suppression contribute significantly to the ongoing HIV epidemic and have an increased risk of clinical sequelae related to immunosuppression. The extent to which substance use and mental health diagnoses affect HIV outcomes and the care continuum has not been previously assessed at the Medical University of South Carolina (MUSC), a large academic HIV clinic. METHODS: To address this knowledge gap and identify targets for intervention, we performed a retrospective chart review to examine associations of substance use and mental health diagnoses with hospitalization and virologic suppression. RESULTS: Patients with substance use or mental health diagnoses had increased rates of hospitalization and lower rates of sustained longitudinal HIV suppression. Prevalence of distinct substance-related disorders differed by race and sex. Although cocaine, alcohol and cannabis use were common, documented opiate use disorder was surprisingly infrequent given the ongoing opioid epidemic in South Carolina. CONCLUSIONS: These data suggest effective assessment and treatment of substance use disorders will help improve the HIV care continuum in South Carolina.
BACKGROUND:Persons with HIV infection who do not achieve virologic suppression contribute significantly to the ongoing HIV epidemic and have an increased risk of clinical sequelae related to immunosuppression. The extent to which substance use and mental health diagnoses affect HIV outcomes and the care continuum has not been previously assessed at the Medical University of South Carolina (MUSC), a large academic HIV clinic. METHODS: To address this knowledge gap and identify targets for intervention, we performed a retrospective chart review to examine associations of substance use and mental health diagnoses with hospitalization and virologic suppression. RESULTS:Patients with substance use or mental health diagnoses had increased rates of hospitalization and lower rates of sustained longitudinal HIV suppression. Prevalence of distinct substance-related disorders differed by race and sex. Although cocaine, alcohol and cannabis use were common, documented opiate use disorder was surprisingly infrequent given the ongoing opioid epidemic in South Carolina. CONCLUSIONS: These data suggest effective assessment and treatment of substance use disorders will help improve the HIV care continuum in South Carolina.
Authors: Andrew Kolodny; David T Courtwright; Catherine S Hwang; Peter Kreiner; John L Eadie; Thomas W Clark; G Caleb Alexander Journal: Annu Rev Public Health Date: 2015-01-12 Impact factor: 21.981
Authors: Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio Journal: JAMA Date: 2016-07-12 Impact factor: 56.272
Authors: Jacek Skarbinski; Eli Rosenberg; Gabriela Paz-Bailey; H Irene Hall; Charles E Rose; Abigail H Viall; Jennifer L Fagan; Amy Lansky; Jonathan H Mermin Journal: JAMA Intern Med Date: 2015-04 Impact factor: 21.873
Authors: Lisa R Metsch; Christine Bell; Margaret Pereyra; Gabriel Cardenas; Tanisha Sullivan; Allan Rodriguez; Lauren Gooden; Nayla Khoury; Tamy Kuper; Toye Brewer; Carlos del Rio Journal: Am J Public Health Date: 2009-04-16 Impact factor: 9.308
Authors: Sophia M Rein; Colette J Smith; Clinton Chaloner; Adam Stafford; Alison J Rodger; Margaret A Johnson; Jeffrey McDonnell; Fiona Burns; Sara Madge; Alec Miners; Lorraine Sherr; Simon Collins; Andrew Speakman; Andrew N Phillips; Fiona C Lampe Journal: EClinicalMedicine Date: 2020-12-01
Authors: Jessica P Ridgway; Arno Uvin; Jessica Schmitt; Tomasz Oliwa; Ellen Almirol; Samantha Devlin; John Schneider Journal: JMIR Med Inform Date: 2021-03-10
Authors: Amy J Kennedy; Kathleen A McGinnis; Jessica S Merlin; E Jennifer Edelman; Adam J Gordon; P Todd Korthuis; Melissa Skanderson; Emily C Williams; Jessica Wyse; Benjamin Oldfield; Kendall Bryant; Amy Justice; David A Fiellin; Kevin L Kraemer Journal: J Subst Abuse Treat Date: 2021-05-29